|
LRRCC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
1.63713487211226E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
7.044200E-01 |
| Stage1-vs-Stage3 |
6.234500E-02 |
| Stage1-vs-Stage4 |
1.649610E-02 |
| Stage2-vs-Stage3 |
1.262370E-01 |
| Stage2-vs-Stage4 |
2.326000E-02 |
| Stage3-vs-Stage4 |
3.780800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
3.29609999960567E-07 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
3.388600E-01 |
| Caucasian-vs-Asian |
4.463600E-01 |
| AfricanAmerican-vs-Asian |
2.225600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
2.705800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.75290000004047E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.952600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.082200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.323600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.836400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.903200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.755000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.15569999999699E-05 |
| Classical-VS-Follicular |
9.050800E-01 |
| Classical-VS-Other |
9.886000E-01 |
| Classical-VS-Normal |
1.99840144432528E-15 |
| Tall-VS-Follicular |
1.398000E-03 |
| Tall-VS-Other |
2.790800E-01 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
9.821200E-01 |
| Follicular-VS-Normal |
1.62880819942757E-12 |
| Other-VS-Normal |
2.233700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62436730732907E-12 |
| N0-vs-N1 |
2.767500E-02 |
|
|
